Paragon 28, Inc. (NYSE:FNA) Receives $14.20 Consensus PT from Brokerages

Paragon 28, Inc. (NYSE:FNA - Get Free Report) has been assigned an average recommendation of "Hold" from the six ratings firms that are covering the company, MarketBeat reports. Four analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $14.20.

FNA has been the subject of a number of recent analyst reports. William Blair downgraded Paragon 28 from an "outperform" rating to a "market perform" rating in a research report on Wednesday, January 29th. Canaccord Genuity Group set a $13.00 price objective on shares of Paragon 28 in a report on Wednesday, January 29th. Stephens reissued an "equal weight" rating and issued a $13.00 price target (down previously from $14.00) on shares of Paragon 28 in a report on Thursday, January 30th. Finally, Needham & Company LLC reissued a "hold" rating and set a $13.00 price target on shares of Paragon 28 in a report on Wednesday, January 29th.

Paragon 28 Trading Up 0.0 %

NYSE:FNA traded up $0.00 on Monday, reaching $13.09. The company's stock had a trading volume of 19,380,085 shares, compared to its average volume of 1,065,459. Paragon 28 has a 12-month low of $4.65 and a 12-month high of $13.13. The stock has a 50 day moving average price of $13.03 and a 200 day moving average price of $10.55. The firm has a market cap of $1.10 billion, a price-to-earnings ratio of -17.69 and a beta of 1.47. The company has a quick ratio of 1.60, a current ratio of 3.50 and a debt-to-equity ratio of 0.79.

Paragon 28 (NYSE:FNA - Get Free Report) last posted its earnings results on Thursday, March 6th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.12) by ($0.01). The firm had revenue of $71.75 million during the quarter, compared to analysts' expectations of $70.81 million. Paragon 28 had a negative net margin of 25.31% and a negative return on equity of 37.90%. On average, equities analysts anticipate that Paragon 28 will post -0.64 EPS for the current fiscal year.

Insider Activity at Paragon 28

In other Paragon 28 news, major shareholder Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock in a transaction dated Thursday, January 23rd. The stock was sold at an average price of $11.63, for a total transaction of $234,181.68. Following the transaction, the insider now directly owns 10,366,009 shares of the company's stock, valued at approximately $120,556,684.67. The trade was a 0.19 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In the last 90 days, insiders have sold 1,875,984 shares of company stock worth $24,359,971. Insiders own 15.32% of the company's stock.

Hedge Funds Weigh In On Paragon 28

Hedge funds have recently added to or reduced their stakes in the stock. Barclays PLC increased its holdings in Paragon 28 by 180.6% during the 3rd quarter. Barclays PLC now owns 84,812 shares of the company's stock worth $567,000 after acquiring an additional 54,591 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Paragon 28 by 2,141.7% during the third quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company's stock valued at $5,243,000 after purchasing an additional 749,865 shares in the last quarter. New York State Common Retirement Fund boosted its stake in Paragon 28 by 374.6% during the 4th quarter. New York State Common Retirement Fund now owns 14,570 shares of the company's stock valued at $151,000 after purchasing an additional 11,500 shares during the last quarter. Rhumbline Advisers lifted its holdings in shares of Paragon 28 by 1.7% during the 4th quarter. Rhumbline Advisers now owns 62,861 shares of the company's stock valued at $649,000 after buying an additional 1,024 shares during the period. Finally, Ballentine Partners LLC increased its stake in shares of Paragon 28 by 15.0% in the 4th quarter. Ballentine Partners LLC now owns 15,630 shares of the company's stock worth $161,000 after purchasing an additional 2,043 shares in the last quarter. Institutional investors and hedge funds own 63.57% of the company's stock.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.